The US Food and Drug Administration on Wednesday authorized Pfizer's antiviral pill, Paxlovid, to treat Covid-19. This is the first antiviral Covid-19 pill authorized for ill people to take at home, before they get sick enough to be hospitalized.
Following FDA emergency use authorisation today EMA endorsement is anticipated early 2022
In the U.S. alone Paxlovid could prevent over half a million deaths and hospitalisations (with respect to the treatment of the high-risk population) in 2022
Today the U.K. confirmed a supply deal for an additional 2.5 million doses of Paxlovid